Stay updated with breaking news from Cipla Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pulmatrix (NASDAQ:PULM – Get Free Report) and Kineta (NASDAQ:KA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and risk. Risk and Volatility Pulmatrix has a beta of 0.74, […]
Pulmatrix (NASDAQ:PULM – Get Free Report) and Kineta (NASDAQ:KA – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, dividends, valuation and earnings. Valuation & Earnings This table compares Pulmatrix and Kineta’s […]
Esperion Therapeutics (NASDAQ:ESPR – Get Free Report) and Pulmatrix (NASDAQ:PULM – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership. Insider and Institutional Ownership 85.5% of Esperion Therapeutics […]
UK-based software-as-a-service platform InVentry on Tuesday said it has bought smart workplace management solutions provider Hipla Technologies Pte Ltd for an undisclosed amount. InVentry said that ......
/PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary...